EPISODE · May 20, 2026 · 1 MIN
Experts Optimistic About SERD Development in HR-Positive Breast Cancer
from TheBrief.Health · host TheBrief.Health
Emerging selective estrogen receptor degraders (SERDs) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life.
What this episode covers
Emerging selective estrogen receptor degraders (SERDs) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life.
NOW PLAYING
Experts Optimistic About SERD Development in HR-Positive Breast Cancer
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m